Martek Biosciences Corporation
Martek Biosciences Corporation, a component of Royal DSM NV,[1] produces nutritional supplements from cultivated fungi and microalgae. The company's products include the omega-3 fatty acid docosahexaenoic acid (DHA) and arachidonic acid (ARA), an omega-6 fatty acid.[2] DHA is used in foods, beverages, infant formula, and supplements. The ARA is used in infant formulas.[3] It is based in Columbia, Maryland, U.S.
Martek Biosciences also produced and sold fluorescent algal proteins for use in life science research applications (microscopy, TR-FRET assays and flow cytometry). This business unit was spun off to form Columbia Biosciences in July 2007.
In early 2010, Martek announced that it is purchasing Amerifit Brands, a consumer health and wellness product company.[4] In the spring of 2010, Martek joined with the National Center for Creative Aging, a DC-based non-profit organization, to develop a campaign called "Beautiful Minds: Finding Your Lifelong Potential." The campaign is designed to inspire baby boomers to be more proactive about their brain health.[5]
DSM announced its acquisition of Martek for US$1.1 billion in December 2010.[6]
References
- ↑ Matthews, Sheenagh DSM Says ‘No Pause’ in Acquisitions as Profit Tops Estimates Bloomberg, Apr 27, 2011.
- ↑ University of Maryland Medical Center, Medical Reference, Complementary Medicine. Docosahexaenoic acid (DHA). Retrieved 4 Jan 2011.
- ↑ Auestad, Nancy, et al. "Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age." Pediatrics 112.3 (2003): 660+. General Reference Center Gold. Web. 4 Jan. 2011.
- ↑ "Martek to pay $200 million for Amerifit Brands".
- ↑ story "Martek Launches Beautiful Minds Campaign" Check
|url=value (help). - ↑ Overly, Steven. "$1.1 billion offered for nutrient producer Martek." Washington Post 22 Dec. 2010: A14. General Reference Center Gold. Web. 4 Jan. 2011.